Olsen KC et al. |
Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules. |
2014 |
Am. J. Respir. Cell Mol. Biol. |
pmid:24175906
|
GarcÃa-Bueno B et al. |
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. |
2014 |
Schizophr Bull |
pmid:23486748
|
Katsumata Y et al. |
Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2. |
2014 |
Hypertension |
pmid:24101662
|
Tachi M et al. |
Mass spectrometric determination of prostanoids in rat hypothalamic paraventricular nucleus microdialysates. |
2014 |
Auton Neurosci |
pmid:24447364
|
Kurtz M et al. |
Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats. |
2014 |
J. Endocrinol. |
pmid:24389592
|
Jung WK et al. |
The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells. |
2014 |
Int. J. Mol. Med. |
pmid:24337644
|
Kang ES et al. |
15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells. |
2014 |
Free Radic. Res. |
pmid:24180671
|
Marcone S and Fitzgerald DJ |
Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2. |
2013 |
Proteomics |
pmid:23606334
|
Sánchez-Gómez FJ et al. |
Modulation of GSTP1-1 oligomerization by electrophilic inflammatory mediators and reactive drugs. |
2013 |
Inflamm Allergy Drug Targets |
pmid:23596995
|
Tan BS et al. |
6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). |
2013 |
Cancer Lett. |
pmid:23612072
|